Notably, numerous rheumatic medications, such as hydroxychloroquine, JAK, and IL‐6 inhibitors, are being investigated to prevent and/or manage COVID‐19 and its consequences.8, 9, 10. This evidence concerns the gene IL6 and COVID-19.